Herpes Simplex Virus Type 2 Glycoprotein G-Specific Antibody, IgG by CIA
Ordering Recommendation
Not a stand-alone test. Order in conjunction with Herpes Simplex Virus Type 1 Glycoprotein G-Specific Antibody, IgG by CIA (0050292).
New York DOH Approval Status
Specimen Required
Serum Separator Tube (SST).
Allow specimen to clot completely at room temperature. Separate from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to an ARUP Standard Transport Tube. (Min: 0.5 mL)
Refrigerated.
Contaminated, heat-inactivated, grossly hemolyzed, lipemic, or severely icteric specimens.
After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles)
Methodology
Semi-Quantitative Chemiluminescent Immunoassay
Performed
Sun-Sat
Reported
1-2 days
Reference Interval
Effective February 18, 2020 |
|
---|---|
0.89 IV or less | Negative - No significant level of detectable IgG antibody to HSV type 2 glycoprotein G. |
0.90-1.09 IV | Equivocal - Questionable presence of IgG antibody to HSV type 2 glycoprotein G. Repeat testing in 10-14 days may be helpful. |
1.10 IV or greater | Positive - IgG antibody to HSV type 2 glycoprotein G detected, which may indicate a current or past HSV infection. |
Interpretive Data
Individuals infected with HSV may not exhibit detectable IgG antibody to type-specific HSV antigens 1 and 2 in the early stages of infection. Detection of antibody presence in these cases may only be possible using a non-type specific screening test.
FDA
Note
For CSF specimens refer to Herpes Simplex Virus Type 2 Glycoprotein G-Specific Antibody, IgG by ELISA, CSF (ARUP test code 0050359).
Hotline History
CPT Codes
86696
Components
Component Test Code* | Component Chart Name | LOINC |
---|---|---|
0050294 | HSV 2 Glycoprotein G Antibody, IgG | 42338-4 |
Aliases
- Herpes Simplex glycoprotein G
- HerpeSelect
- HSV 2 typing
- HSV Type 2 IgG Specific Ab
- HSV typing
- HSV-2